Cargando…
Device-Based Solutions to Improve Cardiac Physiology and Hemodynamics in Heart Failure With Preserved Ejection Fraction
Characterized by a rapidly increasing prevalence, elevated mortality and rehospitalization rates, and inadequacy of pharmaceutical therapies, heart failure with preserved ejection fraction (HFpEF) has motivated the widespread development of device-based solutions. HFpEF is a multifactorial disease o...
Autores principales: | Rosalia, Luca, Ozturk, Caglar, Shoar, Saeed, Fan, Yiling, Malone, Grainne, Cheema, Faisal H., Conway, Claire, Byrne, Robert A., Duffy, Garry P., Malone, Andrew, Roche, Ellen T., Hameed, Aamir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8559325/ https://www.ncbi.nlm.nih.gov/pubmed/34754993 http://dx.doi.org/10.1016/j.jacbts.2021.06.002 |
Ejemplares similares
-
Sudden Death and Ventricular Arrhythmias in Heart Failure With Preserved Ejection Fraction
por: Cho, Jae Hyung
Publicado: (2022) -
Murine Models of Heart Failure With Preserved Ejection Fraction: A “Fishing Expedition”
por: Valero-Muñoz, Maria, et al.
Publicado: (2017) -
Relationship of Nonalcoholic Fatty Liver Disease and Heart Failure With Preserved Ejection Fraction
por: Salah, Husam M., et al.
Publicado: (2021) -
Biomarkers, myocardial fibrosis and co-morbidities in heart failure with preserved ejection fraction: an overview
por: Michalska-Kasiczak, Marta, et al.
Publicado: (2018) -
Clinical Phenotypes of Heart Failure With Preserved Ejection Fraction to Select Preclinical Animal Models
por: van Ham, Willem B., et al.
Publicado: (2022)